- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03062722
Efficacy of Keyhole Approach to Carpal Tunnel Syndrome Under Ambulatory Strategy
February 22, 2017 updated by: Ivan Segura Duran
Efficacy of Keyhole Approach to Carpal Tunnel Syndrome Under Ambulatory
Prospective controlled clinical trial in which a minimally invasive microsurgical approach was used following the keyhole principle in 55 patients and 65 hands under local anesthesia and ambulatory strategy.
All patients included in the study had an average of 3 months disease course and were considered refractory to conservative treatment.
Patients were evaluated with stringent inclusion criteria with the Levine severity and functional status scale with a 2 year follow-up.
Descriptive outcomes on the efficiency of this procedure are reported.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Prospective clinical study to analyze 55 patients with carpal tunnel syndrome treated with open minimally invasive approach in 65 hands, using local anesthesia without tourniquet and in an ambulatory setting.
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with confirmed diagnosis who had neurologic exam, electromyography, cervical spine X rays showing no structural disturbances and with at least 3 months of persistent pain refractory to medical management and physical therapy.
Exclusion Criteria:
- Patients with a history of direct trauma or orthopedic lesions in the carpal region, endocrine and/or metabolic disturbances (hypothyroidism, diabetes) and those that had previous local administration of steroids were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: keyhole approach
open minimally invasive approach
|
The surgical procedure was a direct microsurgical approach with a 1.5 cm incision in the thenar sulcus, under local anesthesia (3cc, 2% lidocaine) administered with an insulin needle.
The keyhole approach applied to this anatomical region is based on a 1.5 cm skin incision from where the 0.5 cm dissection is completed in the subcutaneous plane in the side borders and 1cm in the distal and proximal borders.
Thus, the subcutaneous phase of the dissection is completed with separation of the carpal ligament and resection of its borders.
Once the transverse fibers are open, the perineural micro adhesions of the median nerve are resected and 3mm of the free borders of the carpal fibers found on the nerve are removed to avoid fibrosis.
The wound is checked for hemostasis and closed in apposition with Vicryl 3-0 and a single subdermal 3-0 Nylon stitch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Levine Severity Scale
Time Frame: 2 years follow up
|
pain grades with 5 grades of intensity
|
2 years follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rodrigo Ramos Zuñiga, M.D. PhD, Universidad se Guadalajara
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
February 20, 2017
First Submitted That Met QC Criteria
February 22, 2017
First Posted (Actual)
February 23, 2017
Study Record Updates
Last Update Posted (Actual)
February 23, 2017
Last Update Submitted That Met QC Criteria
February 22, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Wounds and Injuries
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Neuromuscular Diseases
- Neurodegenerative Diseases
- Mononeuropathies
- Peripheral Nervous System Diseases
- Median Neuropathy
- Cumulative Trauma Disorders
- Sprains and Strains
- Heredodegenerative Disorders, Nervous System
- Nervous System Malformations
- Polyneuropathies
- Syndrome
- Carpal Tunnel Syndrome
- Nerve Compression Syndromes
- Charcot-Marie-Tooth Disease
- Hereditary Sensory and Motor Neuropathy
Other Study ID Numbers
- CI.063-2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carpal Tunnel Syndrome
-
Stanford UniversityMayo Clinic; Brown University; Duke University; Harvard University; University of...CompletedCarpal Tunnel Syndrome | Carpal Tunnel | Carpal Tunnel Syndrome Bilateral | Carpal Tunnel Syndrome Left | Carpal Tunnel Syndrome RightUnited States
-
Issa, Abdulhamid Sayed, M.D.CompletedCarpal Tunnel Syndrome | CTS | Carpal Tunnel Release | Carpal Tunnel Surgery | Carpal Tunnel Transverse ApproachSyrian Arab Republic
-
Ohio State UniversityCompletedBilateral Carpal Tunnel Syndrome (Diagnosis)United States
-
University of Split, School of MedicineCompletedCarpal Tunnel Syndrome BilateralCroatia
-
CMC Ambroise ParéCompletedCarpal Tunnel ReleaseFrance
-
Vanderbilt UniversityOrthopedic Research and Education FoundationCompleted
-
University of PittsburghWithdrawnPain After Carpal Tunnel ReleaseUnited States
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingCarpal Tunnel Syndrome BilateralFrance
-
Istituto Ortopedico RizzoliCompletedEntrapment Neuropathy, Carpal Tunnel | Compression Neuropathy, Carpal Tunnel | Median Neuropathy, Carpal TunnelItaly
-
David TangRecruitingCarpal Tunnel Syndrome | Splints | Carpal Tunnel | Nerve Compression | Carpal Tunnel Release | Hand Injuries and DisordersCanada
Clinical Trials on keyhole approach
-
Shanghai Changzheng HospitalThe First Affiliated Hospital of Nanchang University; Peking Union Medical... and other collaboratorsNot yet recruitingHypertensive Intracerebral HemorrhageChina
-
Fudan UniversityNot yet recruitingParastomal Hernia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Medical University of GrazCompletedLiver Cirrhosis | Chronic Hepatitis CAustria
-
The Cleveland ClinicUniversity of Southern CaliforniaRecruitingRadiculopathy, Cervical | Myelopathy, Compressive | C5 PalsyUnited States
-
ZhuQingCompletedIntracranial Aneurysm | Randomized Controlled Trial | Endovascular Procedures | Microsurgery
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Bristol-Myers SquibbTerminatedHealthy Adult VolunteersUnited States
-
SanofiCompleted
-
Masonic Cancer Center, University of MinnesotaTerminatedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Germ Cell TumorUnited States